News | November 14, 2025
Diabetes on the rise: Over 50% of Indians show high blood sugar, reveals report
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
Sumatriptan injection is indicated in adults for the acute treatment of migraine
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
The complex four-hour surgery was performed by a multidisciplinary team of doctors
Merck and mantro GmbH have established EdiMembre, Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry
Vasograin Plus represents a major advancement in the treatment of migraine
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo
Subscribe To Our Newsletter & Stay Updated
